Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A25414 | 21878129 | BMC Res Notes | Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital. | 2011 | Details |
A25426 | 21862168 | Diabetes Res Clin Pract | Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. | 2011 | Details |
A25471 | 21796479 | Endocrine | Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males. | 2011 | Details |
A25499 | 21765869 | Therap Adv Gastroenterol | The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. | 2011 | Details |
A25501 | 21764273 | Nutr Metab Cardiovasc Dis | Obesity and metabolic syndrome: potential benefit from specific nutritional components. | 2011 | Details |
A25504 | 21761549 | Liver Transpl | Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? | 2011 | Details |
A25512 | 21751587 | J Assoc Physicians India | Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. | 2011 | Details |
A25514 | 21750929 | Dig Dis Sci | The relationship between arterial stiffness and nonalcoholic fatty liver disease. | 2011 | Details |
A25538 | 21735081 | Dig Dis Sci | Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. | 2011 | Details |
A25541 | 21734385 | Dig Dis | ASH and NASH. | 2011 | Details |
A25559 | 21711426 | Hepatol Res | NASH: A global health problem. | 2011 | Details |
A25601 | 21664615 | Atherosclerosis | Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. | 2011 | Details |
A25607 | 21655948 | Dig Dis Sci | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. | 2011 | Details |
A25613 | 21645445 | Zhonghua Gan Zang Bing Za Zhi | [General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease]. | 2011 | Details |
A25620 | 21634051 | Clin Res Hepatol Gastroenterol | Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. | 2011 | Details |
A25650 | 21595271 | Nihon Rinsho | [Attenuation of fatty accumulation in hepatocyte by incretin--expectation of novel medicine for treatment of NASH]. | 2011 | Details |
A25656 | 21576832 | Intern Med | The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. | 2011 | Details |
A25659 | 21570483 | Clin Gastroenterol Hepatol | Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. | 2011 | Details |
A25665 | 21565479 | Nutr Metab Cardiovasc Dis | Management of metabolic syndrome in children and adolescents. | 2011 | Details |
A25674 | 21561285 | Scand J Gastroenterol | Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men. | 2011 | Details |
A25694 | 21535445 | Aliment Pharmacol Ther | Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. | 2011 | Details |
A25695 | 21534339 | Turk J Pediatr | Abdominal obesity is an independent risk factor for increased carotid intima- media thickness in obese children. | 2011 | Details |
A25720 | 21508207 | J Nutr | Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. | 2011 | Details |
A25735 | 21495873 | Toxicol Mech Methods | Epigenetic priming of the metabolic syndrome. | 2011 | Details |
A25786 | 21457446 | Liver Int | Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. | 2011 | Details |
A25791 | 21452138 | Ther Umsch | [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. | 2011 | Details |
A25805 | 21440669 | Clin Gastroenterol Hepatol | Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. | 2011 | Details |
A25819 | 21429453 | Arab J Gastroenterol | Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer. | 2011 | Details |
A25821 | 21427524 | J Endocrinol Invest | Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? | 2011 | Details |
A25841 | 21407274 | Nefrologia | Management of HCV infection in chronic kidney disease. | 2011 | Details |
A25849 | 21397104 | Psychosomatics | Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. | 2011 | Details |
A25853 | 21390143 | World J Gastroenterol | Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? | 2011 | Details |
A25854 | 21389796 | Eur J Gastroenterol Hepatol | Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. | 2010 | Details |
A25866 | 21378565 | Curr Opin Lipidol | Lipidomics is providing new insight into the metabolic syndrome and its sequelae. | 2011 | Details |
A25882 | 21356258 | J Hepatol | Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. | 2011 | Details |
A25892 | 21348922 | Obes Rev | Cardiovascular benefits of bariatric surgery in morbidly obese patients. | 2011 | Details |
A25894 | 21348181 | G Ital Cardiol (Rome) | [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. | 2010 | Details |
A25900 | 21342625 | Zhongguo Dang Dai Er Ke Za Zhi | [The prevalence of type 2 diabetes mellitus and prediabetes in children]. | 2011 | Details |
A25915 | 21331995 | Turk J Gastroenterol | Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. | 2010 | Details |
A25922 | 21325336 | Acta Biochim Biophys Sin (Shanghai) | PGC-1 coactivators in the control of energy metabolism. | 2011 | Details |
A25924 | 21320639 | Clin Gastroenterol Hepatol | Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. | 2011 | Details |
A25934 | 21302121 | J Gastroenterol | Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. | 2011 | Details |
A26046 | 21168455 | J Hepatol | Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. | 2010 | Details |
A26066 | 21145850 | J Hepatol | Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? | 2010 | Details |
A26068 | 21145841 | J Hepatol | Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. | 2010 | Details |
A26069 | 21145840 | J Hepatol | The heart in liver transplantation. | 2010 | Details |
A26086 | 21128245 | Int J Cancer | Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. | 2011 | Details |
A26095 | 26190482 | Clin J Gastroenterol | The latest idea in NAFLD/NASH pathogenesis. | 2010 | Details |
A26105 | 21091931 | J Dig Dis | Epidemiology of the metabolic syndrome in the USA. | 2011 | Details |
A26111 | 21077292 | Rinsho Byori | [Chronic liver disease related to impaired glucose tolerance]. | 2010 | Details |
A26113 | 21073649 | Liver Int | Angiogenesis in chronic liver disease and its complications. | 2010 | Details |
A26133 | 21044016 | Curr Vasc Pharmacol | Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment. | 2011 | Details |
A26142 | 21037547 | Minerva Gastroenterol Dietol | Metabolic syndrome and liver transplantation. | 2010 | Details |
A26160 | 20975341 | Am J Surg Pathol | Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. | 2010 | Details |
A26183 | 20943079 | Zhonghua Gan Zang Bing Za Zhi | [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease]. | 2010 | Details |
A26200 | 20922498 | Obes Surg | NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. | 2011 | Details |
A26203 | 20890890 | Hepatology | Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. | 2010 | Details |
A26217 | 28839568 | Frontline Gastroenterol | Practical management of the increasing burden of non-alcoholic fatty liver disease. | 2010 | Details |
A26227 | 20865675 | Cardiol J | Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. | 2010 | Details |
A26232 | 20858492 | Gastroenterology | Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. | 2010 | Details |
A26247 | 20842181 | Nat Rev Endocrinol | Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. | 2010 | Details |
A26256 | 20827318 | Int J Clin Exp Med | Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. | 2010 | Details |
A26258 | 20819880 | J Clin Pathol | Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease. | 2010 | Details |
A26263 | 20817213 | Metabolism | Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. | 2010 | Details |
A26282 | 20733515 | J Clin Gastroenterol | The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. | 2011 | Details |
A26283 | 20731535 | Ups J Med Sci | Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. | 2010 | Details |
A26284 | 20731130 | Eksp Klin Gastroenterol | [Splenoportal blood flow with nonalcoholic fatty liver disease]. | 2010 | Details |
A26312 | 20661251 | Int J Obes (Lond) | Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. | 2010 | Details |
A26325 | 20648476 | Hepatology | Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. | 2010 | Details |
A26329 | 20645852 | Annu Rev Nutr | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 2010 | Details |
A26332 | 20637154 | Zhongguo Dang Dai Er Ke Za Zhi | [Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity]. | 2010 | Details |
A26342 | 20625647 | Arq Bras Endocrinol Metabol | Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2010 | Details |
A26353 | 20604719 | Scand J Clin Lab Invest | Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease. | 2010 | Details |
A26361 | 20590731 | Diabetes Obes Metab | Acupuncture: is it effective for treatment of insulin resistance? | 2010 | Details |
A26390 | 20537997 | Gastroenterology | Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. | 2010 | Details |
A26395 | 20529259 | BMC Gastroenterol | Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. | 2010 | Details |
A26404 | 23148155 | Ther Adv Endocrinol Metab | Advances in the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
A26405 | 22444262 | Animal | Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. | 2010 | Details |
A26409 | 20505515 | Eur J Gastroenterol Hepatol | Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. | 2010 | Details |
A26427 | 20473581 | Obes Surg | Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26435 | 20460923 | Dig Dis | Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. | 2010 | Details |
A26437 | 20460921 | Dig Dis | Endocannabinoids and their role in fatty liver disease. | 2010 | Details |
A26445 | 20460913 | Dig Dis | The role of non-alcoholic fatty liver disease in cardiovascular disease. | 2010 | Details |
A26451 | 20460907 | Dig Dis | Environmental and genetic determinants of fatty liver in humans. | 2010 | Details |
A26452 | 20460906 | Dig Dis | The natural history of non-alcoholic fatty liver disease. | 2010 | Details |
A26463 | 20448542 | Obesity (Silver Spring) | Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. | 2010 | Details |
A26495 | 20394204 | Vnitr Lek | [Prevalence of liver disease markers among patients with metabolic risk factors]. | 2010 | Details |
A26497 | 20392616 | Nutr Metab Cardiovasc Dis | Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26500 | 20391243 | Res Sports Med | Medical consequences of childhood obesity: a Hong Kong perspective. | 2010 | Details |
A26521 | 20370671 | Curr Pharm Des | Current and future therapeutic strategies in NAFLD. | 2010 | Details |
A26526 | 20037278 | Korean J Hepatol | Current status of liver disease in Korea: nonalcoholic fatty liver disease. | 2009 | Details |
A26527 | 20361370 | Chirurg | [Indications and principles of metabolic surgery]. | 2010 | Details |
A26547 | 20227260 | Nutr Metab Cardiovasc Dis | Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. | 2010 | Details |
A26583 | 20165979 | Dig Dis Sci | Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
A26626 | 20076826 | J Gastrointestin Liver Dis | Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver. | 2009 | Details |
A26638 | 20042103 | Lipids Health Dis | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | 2009 | Details |
A26653 | 20040915 | Am J Gastroenterol | Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". | 2009 | Details |
A26657 | 20036859 | Front Biosci (Elite Ed) | Biochemical characteristics and risk factors in non-alcoholic fatty liver. | 2010 | Details |
A26695 | 19942176 | Anesthesiol Clin | Surgery in the patient with liver disease. | 2009 | Details |
A26697 | 19938136 | Liver Transpl | Posttransplant metabolic syndrome: an epidemic waiting to happen. | 2009 | Details |